Literature DB >> 3890777

Characterisation of non-histone nuclear proteins cross reactive with purified rheumatoid factors.

J C Mason, P J Venables, P R Smith, R N Maini.   

Abstract

In order to examine the interactions between isolated rheumatoid factors (RFs) and cell nuclear antigens we have prepared 10 RFs by affinity chromatography against IgG coupled to Sepharose. Of these, seven cross reacted with cell nuclei on indirect immunofluorescence. The nuclear antigen appeared to be DNA histones by indirect immunofluorescence on rat liver, though on immunoblotting the rheumatoid factors also reacted with three non-histone polypeptides which were identified in the soluble fraction of nuclear extracts. We were unable to show any relationship between these polypeptides and rheumatoid arthritis nuclear antigen. These reactions represent a hitherto unrecognised phenomenon, which extends the range of antigens recognised by rheumatoid factors. We suggest that the immunopathogenic significance of RFs may not be restricted to their reactivity with IgG, and that non-histone nuclear proteins merit further investigation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3890777      PMCID: PMC1001633          DOI: 10.1136/ard.44.5.287

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

3.  Certain rheumatoid factors react with nucleosomes.

Authors:  K Hannestad; B D Stollar
Journal:  Nature       Date:  1978-10-19       Impact factor: 49.962

4.  Studies on antibodies to histones by immunofluorescence.

Authors:  E M Tan; J Robinson; P Robitaille
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

5.  Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis.

Authors:  J R Chapman; P J Charles; P J Venables; P J Thompson; P L Haslam; R N Maini; M E Turner Warwick
Journal:  Am Rev Respir Dis       Date:  1984-09

6.  Polyclonal human antibodies to IgG (rheumatoid factors) which cross-react with cell nuclei.

Authors:  K Hannestad; A Johannessen
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

7.  IgM-rheumatoid factors cross-reactive with IgG and a cell nuclear antigen: apparent 'masking' in original serum.

Authors:  P M Johnson
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

8.  Certain rheumatoid factors react with both IgG and an antigen associated with cell nuclei.

Authors:  K Hannestad
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

9.  'In vitro' study of a reaction between the complement system and cellular DNA.

Authors:  A P Peltier; L Cyna; A Dryll
Journal:  Immunology       Date:  1978-11       Impact factor: 7.397

10.  Characteristics of antinuclear antibodies in rheumatoid arthritis. Reactivity of rheumatoid factor with a histone-dependent nuclear antigen.

Authors:  C T Aitcheson; C Peebles; F Joslin; E M Tan
Journal:  Arthritis Rheum       Date:  1980-05
View more
  3 in total

1.  Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.

Authors:  M Londei; C M Savill; A Verhoef; F Brennan; Z A Leech; V Duance; R N Maini; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Human-human hybridoma autoantibodies with both anti-DNA and rheumatoid factor activities.

Authors:  J Rauch; H Tannenbaum; K Straaton; H Massicotte; J Wild
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

3.  Cross-reactive rheumatoid factors in rheumatoid arthritis with extra-articular disease.

Authors:  M Kinoshita; S Aotsuka; R Yokohari
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.